小智港股覆盤 | 7月14日
今日，港股三大指數漲跌互現。截止收盤，恆生指數跌0.22%，報20751點。國企指數跌0.28%，報7125點。恆生科技指數漲0.89%，報4587點。市場約704只個股上漲，896只個股下跌。成交額突破1128.17億港幣，和昨天同期相比增長4.08%。南下資金淨流入5.9億港幣。
盤面上，生物科技板塊集體拉昇。昭衍新藥漲超8%；泰格醫藥漲超6%；藥明生物、方達控股等多股漲超4%；金斯瑞生物科技漲超2%。昭衍新藥漲超8%領漲CXO板塊，6月全球生物醫藥投融資回暖，機構料助力CXO繼續反彈；交銀國際首予藥明生物買入評級，目標價94.11港元。
居家用品板塊大漲靠前。微創醫療漲超8%；啓明醫療-B漲超6%；時代天使漲超5%；歸創通橋-B、先瑞達醫療-B等多股漲超4%。微創醫療拉昇10%領跑醫療器械股，北京試行DRG除外支付利好創新藥械企業；啓明醫療-B升逾4%，經導管人工肺動脈瓣膜系統獲批上市。
海運板塊漲幅較前。東方海外國際、榮豐億控股等多股漲超4%；太平洋航運、勇利投資、海豐國際等多股漲超2%。
綜合電信板塊跌幅居前。華能國際電力股份跌超6%；大唐發電跌超5%；華潤電力、龍源電力、中廣核新能源等多股跌超4%。華能國際電力股份完成發行30億元超短融；大唐發電：京能集團合計減持1.56億股，持股降至4.999%；龍源電力完成發行20億元超短期融資券；中廣核新能源：6月完成發電量1683.5吉瓦時，同比增加13.9%。
CRO板塊跌幅居前。環球信貸集團跌超5%；國美金融科技跌超3%。環球信貸授出1,150萬元有抵押貸款，年息9%。
消費信貸板塊走弱。中國平安跌超5%；中國太保跌超3%；新華保險、中國太平、衆安在線等多股跌超2%。
uSMART智能寫手的信息、數據均來自媒體公開報道，智能寫手不能保證其完全準確，內容僅供參考，不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
